View Post

Memorial Plastic Surgery Joins Komen Houston Race for the Cure

In In The News by Barbara Jacoby0 Comments

On January 27, 2018, Dr. Patrick Hsu and Dr. Kendall Roehl, together with Memorial Plastic Surgery’s staff and patients, are encouraging everyone to join them for the Susan G. Komen Race for the Cure® at the Sam Houston Park in Downtown Houston. Held in various cities in the United States and around the world, the Susan G. Komen Race for …

View Post

First treatment approved for breast cancer with BRCA genetic mutation

In In The News by Barbara Jacoby0 Comments

By: Laurie McGinley From: washingtonpost.com The Food and Drug Administration on Friday cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies. The drug, called Lynparza, already is approved for certain patients with advanced ovarian cancer associated with the same mutations. Richard Pazdur, director of the …

View Post

Could THIS combination cure breast cancer? ‘

In In The News by Barbara Jacoby0 Comments

By: Stephen Matthews From: dailymail.co.uk A combination of immunotherapy and a virus could treat aggressive breast cancer, an ‘absolutely amazing’ study has revealed. Breakthrough research showed the pairing cured up to 90 per cent of mice plagued by triple negative breast cancer – deemed the deadliest form. Canadian scientists are hopeful the findings will lead to a potential cure, as …

View Post

Immune cells play key role in early breast cancer metastasis even before a tumor develops

In In The News by Barbara Jacoby0 Comments

Source: The Mount Sinai Hospital / Mount Sinai School of Medicine From: sciencedaily.com Mount Sinai researchers have discovered that normal immune cells called macrophages, which reside in healthy breast tissue surrounding milk ducts, play a major role in helping early breast cancer cells leave the breast for other parts of the body, potentially creating metastasis before a tumor has even …

View Post

First stereotactic radiotherapy system designed for breast cancer receives FDA clearance

In In The News by Barbara Jacoby0 Comments

Source: University of Maryland School of Medicine From: medicalxpress.com The GammaPod—a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer—has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients. “We believe this novel radiotherapy system has the …

View Post

Simple blood test shows promise to predict risk of breast cancer relapse

In In The News by Barbara Jacoby0 Comments

From: news-medical.net A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict high or low risk of a breast cancer relapse. This is according to data presented today at the 40th annual San Antonio Breast Cancer Symposium. A proof-of-concept study by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) measured the prevalence …